共 50 条
- [41] Ruxolitinib reduces JAK2 p.V617F allele burden in patients with polycythemia vera enrolled in the RESPONSE study Annals of Hematology, 2017, 96 : 1113 - 1120
- [48] Consequences of the JAK2V617F allele burden for the prediction of transformation into myelofibrosis from polycythemia vera and essential thrombocythemia International Journal of Hematology, 2015, 101 : 148 - 153